Bluejay Diagnostics, Inc.

This study aims to validate a new blood test that measures a protein called IL-6. The goal is to see if a specific level of this protein can accurately predict which patients with severe sepsis or septic shock are most likely to die within 28 days. The study will enroll 700 adult…